| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.09 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |